Ultragenyx Pharmaceutical Inc
NASDAQ:RARE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ultragenyx Pharmaceutical Inc
NASDAQ:RARE
|
US |
|
Peoples Financial Services Corp
NASDAQ:PFIS
|
US |
|
NN Group NV
AEX:NN
|
NL |
|
Applied Industrial Technologies Inc
NYSE:AIT
|
US |
|
Virgin Galactic Holdings Inc
NYSE:SPCE
|
US |
|
MS&AD Insurance Group Holdings Inc
TSE:8725
|
JP |
|
Las Vegas Sands Corp
NYSE:LVS
|
US |
|
RWS Holdings PLC
LSE:RWS
|
UK |
|
Stem Inc
NYSE:STEM
|
US |
|
P
|
Pantheon Infrastructure PLC
LSE:PINT
|
UK |
|
NRJ Group SA
PAR:NRG
|
FR |
|
Dolphin Entertainment Inc
NASDAQ:DLPN
|
US |
|
Resona Holdings Inc
TSE:8308
|
JP |
|
E
|
Endeavour Silver Corp
XMUN:EJD
|
CA |
|
D
|
Discover Financial Services
XBER:DC7
|
US |
|
V
|
Vext Science Inc
CNSX:VEXT
|
CA |
Shareholder Yield
Current shareholder yield for RARE is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
RARE Price
Ultragenyx Pharmaceutical Inc
| Average Annual Return | -17.57% |
| Standard Deviation of Annual Returns | 21.39% |
| Max Drawdown | -82% |
| Market Capitalization | 2.4B USD |
| Shares Outstanding | 98 320 000 |
| Percentage of Shares Shorted | 14.38% |
